3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu

IMNR.OB/IMRP.OB...is no longer valid. It has changed to "OCHT.OB"

Started by saffeysite1, June 20, 2005, 08:23:53 AM

Previous topic - Next topic

Terliso

Currently 30.86% ;D
just by looking @ the chart I see 0.17 cents tomorrow...i think so,.. only an opinion ;) :D ;D ;D

422fwhp

I nibbled a bit in the .10's

422fwhp

....all righty then.

plocp

what sup with this one, i thought it will moving, lol, any comment?

422fwhp

Dunno, closed at the 61.8% retracement  :-\

supergeek

guess i should kept my eye on this one. went up 40% the day i bought it, didnt pull the trigger, now its down 50%. Anyone see any hope left in this or should i just cut it loose and chalk this one up to experience.
bob
Bob

Curret Holdings: CRAP, SHIT, POO

plocp

never buy a penny while its falling, play it while it hit the floor and stand still, that's my experience.

Tequity

.13 x .135 nice ;D ;D ;D

Friday , February 10, 2006 08:26 ET

The Immune Response Corporation (IMNR) announced that the final results from a Phase II clinical study indicate that the Company's whole-inactivated HIV-1 immunogen induces HIV-specific immune responses in HIV-infected, antiretroviral drug-naive patients. Specifically, this original formulation product showed potential to stimulate key immunologic parameters and to stabilize the loss of CD4+ cells, which could help prolong the time before these patients need to initiate antiretroviral therapy. The poster was presented at this week's 13th Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

"CD4+ counts may be an especially important marker of disease progression and we plan to build on this data with our most potent clinical candidate, IR103," noted Joseph O'Neill, M.D., President and Chief Executive Officer of The Immune Response Corporation. "We have two ongoing clinical studies that will investigate IR103 in the drug-naive patient population. We will be expanding them and look forward to reporting the findings."

422fwhp

Target price?

Is Monday the exit day or is this far from over?

supergeek

After being down 50% on wednesday, i closed my position yesterday with a 40+% gain. i've had too many losses recently to turn down a sure gain. although i expect it now to rocket 300% or more monday since i am out. Good luck to all those still invested.

Bob
Bob

Curret Holdings: CRAP, SHIT, POO

marsgold

Look great this morning.(in at 0,16$; I will see if it was a good price or not)

MARS

422fwhp

I think you bought my shares!   ;)

Applaud for this pic...I'm out now with a nice 66% gain in a week.

Jody

marsgold

Not doing very well since I have buy. :-\
Volume is still huge but we have to pass 0,17 for have a nice run.

MARS

metro

Looking interesting in here for possible bo - thanks Doc

       

Live chart
http://tinyurl.com/nextu

marsgold

I have buy some yesterday at 0,11$ but sell them at 0,125$.
I still have the one at 0,17$ and a few at 0,139$.
I am loooking tomorow for add but if we have a huge gap I will just keep mine and wait to sell them.
Anyway, I will see tomorow.
In 10 year, it is the most stressfull play.

MARS